IndiaTickerLatest filing: Copy of Newspaper Publication - Senores Pharmaceuticals Limited
ObservedCompany dossier
Senores Pharmaceuticals
NSE:SENORES · ISIN INE0RB801010
- Close
- ₹1,318.3 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Senores Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹103 Cr · PAT ₹16.4 Cr.
Exchange XBRLLatest ownership: promoter group 45.82% and public 54.18% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Copy of Newspaper Publication - Senores Pharmaceuticals Limited
NSE · financial results
Observed
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Senores Pharmaceuticals Limited
NSE · conference call
Observed
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recording
BSE · conference call recording
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹103 Cr
- Profit after tax
- ₹16.4 Cr
- EPS
- ₹5.04
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 45.82%
- Public
- 54.18%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL